REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Centralinaya Raionnaya Apteka (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Centralinaya Raionnaya Apteka Profile Updated: August 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Russian Download a sample report

MUP Centralinaya Raionnaya Apteka is a company in Russia, with a head office in Krasnokamensk. The company operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on March 14, 1995. From the latest financial highlights, MUP Centralinaya Raionnaya Apteka reported a net sales revenue drop of 4.63% in 2021. Its total assets decreased by 1.92% over the same period. The net profit margin of MUP Centralinaya Raionnaya Apteka decreased by 0.36% in 2021.

Headquarters
6-i, 619, 1
Krasnokamensk; Zabaykalsky Krai; Postal Code: 674673

Contact Details: Purchase the MUP Centralinaya Raionnaya Apteka report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Centralinaya Raionnaya Apteka report to view the information.
Incorporation Date:
March 14, 1995
Key Executives
Purchase this report to view the information.
Acting Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after MUP Centralinaya Raionnaya Apteka report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-4.63%
Total operating revenue
-4.63%
Operating profit (EBIT)
-63.15%
Net Profit (Loss) for the Period
-36.9%
Total assets
-1.92%
Total equity
-1.92%
Operating Profit Margin (ROS)
-1.28%
Net Profit Margin
-0.36%
Return on Equity (ROE)
-1.85%
Quick Ratio
3.17%
Cash Ratio
4.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?